An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult
BackgroundAvoidant/restrictive food intake disorder (ARFID), a DSM-5-introduced eating disorder, is increasingly prevalent and challenging to treat, primarily affecting children and adolescents, with limited adult case reports. This rarity in adults leads to misdiagnosis or underdiagnosis, and treat...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1450800/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841527639027744768 |
|---|---|
| author | Meichen Liu Yiheng Chang Xueting Xie Yudan Liu Shiyun Tian Chun Yang Ziqi Zhao Huimin Zhang |
| author_facet | Meichen Liu Yiheng Chang Xueting Xie Yudan Liu Shiyun Tian Chun Yang Ziqi Zhao Huimin Zhang |
| author_sort | Meichen Liu |
| collection | DOAJ |
| description | BackgroundAvoidant/restrictive food intake disorder (ARFID), a DSM-5-introduced eating disorder, is increasingly prevalent and challenging to treat, primarily affecting children and adolescents, with limited adult case reports. This rarity in adults leads to misdiagnosis or underdiagnosis, and treatment experiences are scarce.Case presentationThis report details an adult ARFID case, where the patient’s fear of food intake followed gastric damage from corn ingestion, resulting in a restrictive diet of rice porridge due to gastric pain. The behavior is driven by fear of eating-related adverse effects.ResultBased on clinical symptoms assessment, semi-structured interviews, and comprehensive testing, including PET/MRI scans to exclude secondary conditions, a diagnosis of ARFID was confirmed. ARFID, a newly introduced diagnosis in the DSM-5, is uncommon in adults with sparse case data. Differentiating it from gastrointestinal diseases and other psychiatric conditions is crucial for precise diagnosis and focused treatment.ConclusionIn this paper, we report on the clinical diagnosis, imaging manifestations, treatment, and follow-up of an adult ARFID case, highlighting the utility of neuroimaging in diagnosis and differentiation. It also assesses the therapeutic efficacy of olanzapine, escitalopram oxalate, and fluoxetine hydrobromide, offering clinical guidance for diagnosing and managing ARFID. |
| format | Article |
| id | doaj-art-cedd67c6d95948c2b8f58b65379e3ec6 |
| institution | Kabale University |
| issn | 1664-0640 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychiatry |
| spelling | doaj-art-cedd67c6d95948c2b8f58b65379e3ec62025-01-15T11:05:44ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402025-01-011510.3389/fpsyt.2024.14508001450800An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adultMeichen Liu0Yiheng Chang1Xueting Xie2Yudan Liu3Shiyun Tian4Chun Yang5Ziqi Zhao6Huimin Zhang7Department of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of Radiology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of Radiology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of General Surgery, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaDepartment of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian, ChinaBackgroundAvoidant/restrictive food intake disorder (ARFID), a DSM-5-introduced eating disorder, is increasingly prevalent and challenging to treat, primarily affecting children and adolescents, with limited adult case reports. This rarity in adults leads to misdiagnosis or underdiagnosis, and treatment experiences are scarce.Case presentationThis report details an adult ARFID case, where the patient’s fear of food intake followed gastric damage from corn ingestion, resulting in a restrictive diet of rice porridge due to gastric pain. The behavior is driven by fear of eating-related adverse effects.ResultBased on clinical symptoms assessment, semi-structured interviews, and comprehensive testing, including PET/MRI scans to exclude secondary conditions, a diagnosis of ARFID was confirmed. ARFID, a newly introduced diagnosis in the DSM-5, is uncommon in adults with sparse case data. Differentiating it from gastrointestinal diseases and other psychiatric conditions is crucial for precise diagnosis and focused treatment.ConclusionIn this paper, we report on the clinical diagnosis, imaging manifestations, treatment, and follow-up of an adult ARFID case, highlighting the utility of neuroimaging in diagnosis and differentiation. It also assesses the therapeutic efficacy of olanzapine, escitalopram oxalate, and fluoxetine hydrobromide, offering clinical guidance for diagnosing and managing ARFID.https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1450800/fullavoidant/restrictive food intake disordermagnetic resonance imagingpositron emission tomographyolanzapineescitalopramfluoxetine |
| spellingShingle | Meichen Liu Yiheng Chang Xueting Xie Yudan Liu Shiyun Tian Chun Yang Ziqi Zhao Huimin Zhang An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult Frontiers in Psychiatry avoidant/restrictive food intake disorder magnetic resonance imaging positron emission tomography olanzapine escitalopram fluoxetine |
| title | An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult |
| title_full | An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult |
| title_fullStr | An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult |
| title_full_unstemmed | An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult |
| title_short | An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult |
| title_sort | arfid case report assessment with 18f fdg pet mri and treatment with olanzapine escitalopram and fluoxetine in adult |
| topic | avoidant/restrictive food intake disorder magnetic resonance imaging positron emission tomography olanzapine escitalopram fluoxetine |
| url | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1450800/full |
| work_keys_str_mv | AT meichenliu anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT yihengchang anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT xuetingxie anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT yudanliu anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT shiyuntian anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT chunyang anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT ziqizhao anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT huiminzhang anarfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT meichenliu arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT yihengchang arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT xuetingxie arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT yudanliu arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT shiyuntian arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT chunyang arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT ziqizhao arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult AT huiminzhang arfidcasereportassessmentwith18ffdgpetmriandtreatmentwitholanzapineescitalopramandfluoxetineinadult |